Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Heart Rhythm. 2016 May 5;13(8):1652–1660. doi: 10.1016/j.hrthm.2016.05.004

Table 1. Clinical and genetic characteristics of family BFC.

Code Sex Current age (y) Diagnosis Age at CPVT diagnosis Genotype Diagnostic criterion SCD/RCA/VT Syncope ICD App ICD Therapy β-Blocker
I-2 F 92 Normal NA −/− NA No No No NA No
II-2 F 64 CPVT 23 +/− Bidirectional VT on EST Yes Yes Yes Yes Yes
II-3 M Deceased aged 16 MVA NA NA Unknown NA No NA NA NA
II-4 M 62 Normal NA −/− No No No No NA No
II-7 F 61 CPVT 51 +/− Polymorphic ectopy on EST Yes Yes Yes No Yes
II-9 F 58 Normal NA −/− No No No No No No
III-1 F 41 Normal NA −/− No No No Yes No No
III-3 F 38 CPVT 31 +/− Polymorphic ectopy on EST Yes Yes Yes Yes Yes
III-5 M 34 Normal NA −/− No No No No NA No
III-11 M 33 Normal NA −/− No No No No NA No
III-13 F 32 CPVT 28 +/− Polymorphic ectopy on EST No No Yes No Yes
IV-1 F Deceased aged 5 CPVT/SCD 5 +/− Unexplained sudden death in CPVT family Yes No No No No
IV-2 F 4 CPVT 3 +/− Polymorphic ectopy on adrenaline challenge No No No NA Yes
IV-6 F 1.5 Possible CPVT NA NA Atrial arrhythmias on adrenaline challenge No No No NA Yes

−/− = no variant identified; +/− = presence of Lysl80Arg variant; App ICD therapy = appropriate implantable cardioverter-defibrillator therapy; CPVT= catecholaminergic polymorphic ventricular tachycardia; EST= exercise stress test; F= female; ICD =implantable cardioverter-defibrillator; M = male; MVA = motor vehicle accident; NA = not applicable; RCA = resuscitated cardiac arrest; SCD = sudden cardiac death;